IDYA - CIK 0001676725
IDEAYA Biosciences, Inc. (IDYA) reported net income of -$113.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$113.70M | +58.6% |
| FY 2024 | -$274.48M | -143.0% |
| FY 2023 | -$112.96M | -92.6% |
| FY 2022 | -$58.66M | -17.9% |
| FY 2021 | -$49.76M | -44.3% |
| FY 2020 | -$34.49M | +17.8% |
| FY 2019 | -$41.98M | -22.2% |
| FY 2018 | -$34.35M | -189.5% |
| FY 2017 |
IDEAYA Biosciences, Inc. (IDYA) reported net income of -$113.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, IDEAYA Biosciences, Inc.'s net income declined from -$11.86M to -$113.70M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$11.86M |
| - |